Follow
Felicia Lim
Felicia Lim
Verified email at duke.edu
Title
Cited by
Cited by
Year
Estrogen receptor signaling in the immune system
B Chakraborty, J Byemerwa, T Krebs, F Lim, CY Chang, DP McDonnell
Endocrine reviews 44 (1), 117-141, 2023
582023
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma
B Chakraborty, J Byemerwa, J Shepherd, CN Haines, R Baldi, W Gong, ...
The Journal of clinical investigation 131 (23), 2021
512021
Turning up the heat: Oncolytic virus MEM-288 induces anti-tumoral immune response in pre-clinical models of high grade serous ovarian cancer (190)
P Peters, R Whitaker, F Lim, S Russell, J Pollara, E Bloom, K Strickland, ...
Gynecologic Oncology 176, S77, 2023
2023
Oncolytic Adenovirus Mem-288 Encoding Membrane-Stable Cd40l and Ifnβ Induces an Anti-Tumor Immune Response in High Grade Serous Ovarian Cancer
P Peters, RS Whitaker, F Lim, S Russell, EA Bloom, J Pollara, ...
Available at SSRN 4804344, 2022
2022
Abstract B05: Assessing estrogen receptor signaling and function in dendritic cells within the tumor microenvironment
F Lim, C Haines, CY Chang, D Mcdonnell
Cancer Immunology Research 10 (12_Supplement), B05-B05, 2022
2022
Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer
S Russell, F Lim, PN Peters, SE Wardell, R Whitaker, CY Chang, ...
Cancers 14 (17), 4219, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6